Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-05-19 | 2023-06-23 | 192818 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-04-06 | 2023-04-21 | 188973 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-11-28 | 2018-01-22 | 31039 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-10-07 | 2021-02-23 | 125824 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-06 | 2024-11-15 | 209286 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-17 | 2017-10-24 | 15995 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-09-28 | 2024-11-15 | 205480 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-05-19 | 2023-07-21 | 192800 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-09-17 | 2021-02-23 | 124359 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-08-19 | 2022-10-14 | 167421 |
| APO-TELMISARTAN | 40MG | TABLET | Resolved | 2017-06-06 | 2017-10-03 | 12080 |
| APO-TELMISARTAN | 40MG | TABLET | Resolved | 2018-07-11 | 2018-07-11 | 55290 |
| APO-TELMISARTAN | 80MG | TABLET | Resolved | 2018-07-15 | 2018-09-12 | 55798 |
| APO-TELMISARTAN | 40MG | TABLET | Resolved | 2018-07-15 | 2018-09-12 | 55794 |
| APO-TELMISARTAN | 80MG | TABLET | Resolved | 2017-05-24 | 2017-10-03 | 11047 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Resolved | 2017-04-11 | 2018-09-12 | 6524 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Resolved | 2017-03-13 | 2017-03-31 | 748 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Resolved | 2017-05-04 | 2018-09-12 | 8922 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Actual shortage | 2017-05-24 | 2018-12-20 | 11050 |
| APO-TENOFOVIR | 300MG | TABLET | Resolved | 2018-07-25 | 2018-09-04 | 56538 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-07-12 | 2019-07-13 | 89135 |
| IBUPROFEN LIQUID GEL CAPSULES | 200MG | CAPSULE | Discontinued | 2019-01-03 | 2019-01-03 | 71095 |
| IMIPRAMINE | 50MG | TABLET | Discontinued | 2017-03-28 | 2017-03-28 | 4593 |
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |